心臓 不全 は 循環 要因 に よっ て 腫瘍 の 成長 を 刺激 する
Wouter C Meijers1, Manuel Maglione2, Stephan J L Bakker3
1Department of Cardiology (W.C.M., D.J.v.V., B.D.W., P.v.d.M., H.H.W.S., R.A.d.B.).
Circulation
|February 21, 2018
まとめ
心不全 (HF) は,がんのリスクの増加と関連しています. この研究はHFが 心臓の要因によって腫瘍の成長を促進し,HFが癌のリスク要因であることを示唆しています.
科学分野:
- 心臓病科
- 腫瘍学
- 翻訳医学
背景:
- 心不全 (HF) の生存率の改善は,がんを含む非心疾患による死亡につながる.
- HFと癌の発症の間の潜在的な因果関係を調査することは極めて重要です.
研究 の 目的:
- 心不全 (HF) ががん発症に因果的に影響するかどうかを判断する.
- 癌の発生に寄与する心臓系因子を特定する.
主な方法:
- 腫瘍の成長を評価するために,誘発性心筋梗塞のAPCミンマウスを使用した.
- ヘテロトピック心臓移植を用いて,血動力学的障害からHFの影響を隔離した.
- 分析された候補分泌タンパク質とその結腸がん細胞への影響
- 一般集団における新発がんと相関する心臓および炎症バイオマーカー.
主要な成果:
- 心不全はマウスの腸内腫瘍の負荷を 2.4 倍に増加させた.
- 左心室機能障害と傷跡の重さは 腫瘍の成長と相関しています
- タンパク質の増加 (セルピンA3,フィブロネクチンなど) serpinA3は結腸がん細胞の増殖を促した.
- 心臓と炎症のバイオマーカーは ヒトの新発がんを予測しました
結論:
- 心不全 (HF) の存在は,血液動力学的要因とは無関係に腫瘍の成長を促進する.
- 心臓が分泌する要因は,HFと癌との関連を媒介する可能性があります.
- HFの診断は,発生がんの危険因子として考慮されるべきです.
関連する概念動画
Heart Failure VI: Adjunct Therapies
395
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
395
Heart Failure V: Medical Management
360
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
360
Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Heart Failure I: Introduction
951
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
951
Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K


